These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24129107)

  • 1. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.
    Asiaf A; Ahmad ST; Mohammad SO; Zargar MA
    Eur J Cancer Prev; 2014 May; 23(3):206-24. PubMed ID: 24129107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus and vaccination in cervical cancer.
    Wang KL
    Taiwan J Obstet Gynecol; 2007 Dec; 46(4):352-62. PubMed ID: 18182340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of cervical cancer.
    Ibeanu OA
    Cancer Biol Ther; 2011 Feb; 11(3):295-306. PubMed ID: 21239888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K
    Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.
    Van de Velde N; Boily MC; Drolet M; Franco EL; Mayrand MH; Kliewer EV; Coutlée F; Laprise JF; Malagón T; Brisson M
    J Natl Cancer Inst; 2012 Nov; 104(22):1712-23. PubMed ID: 23104323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What should be known for the introduction of an HPV vaccine?].
    Muñoz N; Jacquard AC
    Presse Med; 2008 Oct; 37(10):1377-90. PubMed ID: 18786806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
    Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
    Front Immunol; 2020; 11():188. PubMed ID: 32133000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
    McIntosh J; Sturpe DA; Khanna N
    J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects and prejudices of human papillomavirus vaccines in India.
    Das BC; Hussain S; Nasare V; Bharadwaj M
    Vaccine; 2008 May; 26(22):2669-79. PubMed ID: 18455843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus as a target for management, prevention and therapy.
    Crosbie EJ; Kitchener HC
    Int J Hyperthermia; 2012; 28(6):478-88. PubMed ID: 22690976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.
    McKeage K; Romanowski B
    Drugs; 2011 Mar; 71(4):465-88. PubMed ID: 21395359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV vaccines - A review of the first decade.
    Harper DM; DeMars LR
    Gynecol Oncol; 2017 Jul; 146(1):196-204. PubMed ID: 28442134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.
    Hung CF; Ma B; Monie A; Tsen SW; Wu TC
    Expert Opin Biol Ther; 2008 Apr; 8(4):421-39. PubMed ID: 18352847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.
    Castellsagué X; Schneider A; Kaufmann AM; Bosch FX
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S15-23. PubMed ID: 19819540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human papillomavirus high-risk genotypes in rural women of Lucknow, North India.
    Srivastava AN; Misra JS; Rizvi S
    J Cancer Res Ther; 2021; 17(6):1468-1472. PubMed ID: 34916379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.